Literature DB >> 19051289

Association of AKT1 with verbal learning, verbal memory, and regional cortical gray matter density in twins.

Olli P H Pietiläinen1, Tiina Paunio, Anu Loukola, Annamari Tuulio-Henriksson, Tuula Kieseppä, Paul Thompson, Arthur W Toga, Theo G M van Erp, Karri Silventoinen, Pia Soronen, William Hennah, Joni A Turunen, Juho Wedenoja, Outi M Palo, Kaisa Silander, Jouko Lönnqvist, Jaakko Kaprio, Tyrone D Cannon, Leena Peltonen.   

Abstract

AKT1, encoding the protein kinase B, has been associated with the genetic etiology of schizophrenia and bipolar disorder. However, minuscule data exist on the role of different alleles of AKT1 in measurable quantitative endophenotypes, such as cognitive abilities and neuroanatomical features, showing deviations in schizophrenia and bipolar disorder. We evaluated the contribution of AKT1 to quantitative cognitive traits and 3D high-resolution neuroanatomical images in a Finnish twin sample consisting of 298 twins: 61 pairs with schizophrenia (8 concordant), 31 pairs with bipolar disorder (5 concordant) and 65 control pairs matched for age, sex and demographics. An AKT1 allele defined by the SNP rs1130214 located in the UTR of the gene revealed association with cognitive traits related to verbal learning and memory (P = 0.0005 for a composite index). This association was further fortified by a higher degree of resemblance of verbal memory capacity in pairs sharing the rs1130214 genotype compared to pairs not sharing the genotype. Furthermore, the same allele was also associated with decreased gray matter density in medial and dorsolateral prefrontal cortex (P < 0.05). Our findings support the role of AKT1 in the genetic background of cognitive and anatomical features, known to be affected by psychotic disorders. The established association of the same allelic variant of AKT1 with both cognitive and neuroanatomical aberrations could suggest that AKT1 exerts its effect on verbal learning and memory via neural networks involving prefrontal cortex. 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19051289      PMCID: PMC2708342          DOI: 10.1002/ajmg.b.30890

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  47 in total

1.  A general test of association for quantitative traits in nuclear families.

Authors:  G R Abecasis; L R Cardon; W O Cookson
Journal:  Am J Hum Genet       Date:  2000-01       Impact factor: 11.025

2.  Heritability and number of quantitative trait loci of neurocognitive functions in families with schizophrenia.

Authors:  Annamari Tuulio-Henriksson; Jari Haukka; Timo Partonen; Teppo Varilo; Tiina Paunio; Jesper Ekelund; Tyrone D Cannon; Joanne M Meyer; Jouko Lönnqvist
Journal:  Am J Med Genet       Date:  2002-07-08

Review 3.  Structural brain imaging evidence for multiple pathological processes at different stages of brain development in schizophrenia.

Authors:  Christos Pantelis; Murat Yücel; Stephen J Wood; Dennis Velakoulis; Daqiang Sun; Gregor Berger; Geoff W Stuart; Alison Yung; Lisa Phillips; Patrick D McGorry
Journal:  Schizophr Bull       Date:  2005-07-14       Impact factor: 9.306

4.  Pedigree tests of transmission disequilibrium.

Authors:  G R Abecasis; W O Cookson; L R Cardon
Journal:  Eur J Hum Genet       Date:  2000-07       Impact factor: 4.246

5.  A comparative profile analysis of neuropsychological functioning in patients with schizophrenia and bipolar psychoses.

Authors:  Larry J Seidman; William S Kremen; Danny Koren; Stephen V Faraone; Jill M Goldstein; Ming T Tsuang
Journal:  Schizophr Res       Date:  2002-01-01       Impact factor: 4.939

6.  Relative risk for cognitive impairments in siblings of patients with schizophrenia.

Authors:  M F Egan; T E Goldberg; T Gscheidle; M Weirich; R Rawlings; T M Hyde; L Bigelow; D R Weinberger
Journal:  Biol Psychiatry       Date:  2001-07-15       Impact factor: 13.382

7.  The inheritance of neuropsychological dysfunction in twins discordant for schizophrenia.

Authors:  T D Cannon; M O Huttunen; J Lonnqvist; A Tuulio-Henriksson; T Pirkola; D Glahn; J Finkelstein; M Hietanen; J Kaprio; M Koskenvuo
Journal:  Am J Hum Genet       Date:  2000-07-03       Impact factor: 11.025

8.  Further evidence for association of variants in the AKT1 gene with schizophrenia in a sample of European sib-pair families.

Authors:  Sibylle G Schwab; Barbara Hoefgen; Claudia Hanses; Margitta Borrmann Hassenbach; Margot Albus; Bernard Lerer; Matyas Trixler; Wolfgang Maier; Dieter B Wildenauer
Journal:  Biol Psychiatry       Date:  2005-09-15       Impact factor: 13.382

Review 9.  The neurodevelopmental model of schizophrenia: update 2005.

Authors:  J L Rapoport; A M Addington; S Frangou; M R C Psych
Journal:  Mol Psychiatry       Date:  2005-05       Impact factor: 15.992

Review 10.  Bipolar disorder: an update.

Authors:  Barkur S Shastry
Journal:  Neurochem Int       Date:  2005-03       Impact factor: 3.921

View more
  15 in total

Review 1.  Imaging genomics.

Authors:  Paul M Thompson; Nicholas G Martin; Margaret J Wright
Journal:  Curr Opin Neurol       Date:  2010-08       Impact factor: 5.710

2.  Covariance modeling of MRI brain volumes in memory circuitry in schizophrenia: Sex differences are critical.

Authors:  Brandon Abbs; Lichen Liang; Nikos Makris; Ming Tsuang; Larry J Seidman; Jill M Goldstein
Journal:  Neuroimage       Date:  2011-04-08       Impact factor: 6.556

3.  Mapping genetic influences on ventricular structure in twins.

Authors:  Yi-Yu Chou; Natasha Leporé; Ming-Chang Chiang; Christina Avedissian; Marina Barysheva; Katie L McMahon; Greig I de Zubicaray; Matthew Meredith; Margaret J Wright; Arthur W Toga; Paul M Thompson
Journal:  Neuroimage       Date:  2008-11-07       Impact factor: 6.556

4.  Mapping the regional influence of genetics on brain structure variability--a tensor-based morphometry study.

Authors:  Caroline C Brun; Natasha Leporé; Xavier Pennec; Agatha D Lee; Marina Barysheva; Sarah K Madsen; Christina Avedissian; Yi-Yu Chou; Greig I de Zubicaray; Katie L McMahon; Margaret J Wright; Arthur W Toga; Paul M Thompson
Journal:  Neuroimage       Date:  2009-05-14       Impact factor: 6.556

5.  Association of MTHFR C677T polymorphism with schizophrenia and its effect on episodic memory and gray matter density in patients.

Authors:  Yanling Zhang; Hao Yan; Lin Tian; Fang Wang; Tianlan Lu; Lifang Wang; Jun Yan; Qi Liu; Lan Kang; Yanyan Ruan; Dai Zhang; Weihua Yue
Journal:  Behav Brain Res       Date:  2013-01-12       Impact factor: 3.332

Review 6.  The impact of genetic research on our understanding of normal cognitive ageing: 1995 to 2009.

Authors:  Antony Payton
Journal:  Neuropsychol Rev       Date:  2009-09-19       Impact factor: 7.444

7.  Genome-wide association study of working memory brain activation.

Authors:  Gabriëlla A M Blokland; Angus K Wallace; Narelle K Hansell; Paul M Thompson; Ian B Hickie; Grant W Montgomery; Nicholas G Martin; Katie L McMahon; Greig I de Zubicaray; Margaret J Wright
Journal:  Int J Psychophysiol       Date:  2016-09-23       Impact factor: 2.997

8.  A genome-wide study of common SNPs and CNVs in cognitive performance in the CANTAB.

Authors:  Anna C Need; Deborah K Attix; Jill M McEvoy; Elizabeth T Cirulli; Kristen L Linney; Priscilla Hunt; Dongliang Ge; Erin L Heinzen; Jessica M Maia; Kevin V Shianna; Michael E Weale; Lynn F Cherkas; Gail Clement; Tim D Spector; Greg Gibson; David B Goldstein
Journal:  Hum Mol Genet       Date:  2009-09-04       Impact factor: 6.150

9.  Neurodevelopmental concepts of schizophrenia in the genome-wide association era: AKT/mTOR signaling as a pathological mediator of genetic and environmental programming during development.

Authors:  Kristy R Howell; Amanda J Law
Journal:  Schizophr Res       Date:  2019-09-12       Impact factor: 4.939

10.  Epistatic interactions of AKT1 on human medial temporal lobe biology and pharmacogenetic implications.

Authors:  H Y Tan; A G Chen; Q Chen; L B Browne; B Verchinski; B Kolachana; F Zhang; J Apud; J H Callicott; V S Mattay; D R Weinberger
Journal:  Mol Psychiatry       Date:  2011-07-26       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.